Back to top

Enzo Biochem, Inc. (ENZ) Shows Strength: Stock Up 5.2%
March 21, 2017

Read MoreHide Full Article

Enzo Biochem, Inc. (ENZ - Free Report) was a big mover last session, as the company saw its shares rise above 5% on the day. The upside was driven by the company’s improved results for the second-quarter fiscal 2017. Also, this led to far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $6.45 to $7.05 in the past one-month time frame.

The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
 
Enzo Biochem currently carries a Zacks Rank #3 (Hold).
 

A better-ranked stock in the Medical – Biomedical and Genetics industry is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ENZ going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Enzo Biochem, Inc. (ENZ) - free report >>

Anthera Pharmaceuticals, Inc. (ANTH) - free report >>


More from Zacks Tale of the Tape

You May Like